moh-20260722 0001179929 false 0001179929 2026-07-22 2026-07-22 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ______________ FORM 8-K ______________ Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 22, 2026 ______________ MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) ______________ 200 Oceangate, Suite 100, Long Beach, California 90802 (Address of principal executive offices) (Zip Code) Registrant’s telephone number, including area code: ( 562 ) 435-3666 N/A (Former name or former address, if changed since last report.) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.001 Par Value MOH New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section13(a) of the Exchange Act. ☐ Item 2.02.    Results of Operations and Financial Condition. On July 22, 2026, Molina Healthcare, Inc. (the “Company”) issued a press release reporting its financial results for the second quarter ended June 30, 2026 and increasing the Company’s full-year 2026 earnings guidance. The full text of the press release is included as Exhibit 99.1 to this report. The information contained in the Company’s website cited in the press release is not part of this report. Note: The information in this Form 8-K and the exhibits attached hereto shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing. Item 9.01.    Financial Statements and Exhibits. (d)       Exhibits: Exhibit No. Description 99.1 Press release of Molina Healthcare, Inc., issued July 22, 2026. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. MOLINA HEALTHCARE, INC. Date: July 22, 2026 By: /s/ Jeff D. Barlow Jeff D. Barlow Chief Legal Officer and Secretary

Molina Healthcare reported Q2 2026 results on July 22, 2026, and raised its full-year 2026 earnings guidance, signaling strong operational performance and increased confidence in financial outcomes.

On July 22, 2026, Molina Healthcare, Inc. reported its financial results for the second quarter ended June 30, 2026, showing significant performance metrics. The company also announced an increase in its full-year 2026 earnings guidance, indicating confidence in its financial health moving forward. The press release detailing these results is included as Exhibit 99.1 of the filing. This update could have positive implications for investor relations and market perception of Molina Healthcare's growth potential.

Molina Healthcare, Inc.

AI Executive Summary

Key Takeaways

Raw Filing Content

Filing Overview

What This Means